WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001085183) PREPARATION FOR THE PREVENTION AND TREATMENT OF OCULAR DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/085183    International Application No.:    PCT/NL2001/000348
Publication Date: 15.11.2001 International Filing Date: 08.05.2001
Chapter 2 Demand Filed:    06.12.2001    
IPC:
A61K 35/00 (2006.01), A61P 27/02 (2006.01), A61P 27/04 (2006.01), A61P 27/06 (2006.01), A61P 27/12 (2006.01)
Applicants: N.V. NUTRICIA [NL/NL]; P.O. Box 1 NL-2700 MA Zoetermeer (NL) (For All Designated States Except US).
VERDEGEM, Peter, Julien, Edward [NL/NL]; (NL) (For US Only)
Inventors: VERDEGEM, Peter, Julien, Edward; (NL)
Agent: JORRITSMA, Ruurd; Nederlandsch Octroibureau Scheveningseweg 82 P.O. Box 29720 NL-2502 LS The Hague (NL)
Priority Data:
09/566,385 08.05.2000 US
Title (EN) PREPARATION FOR THE PREVENTION AND TREATMENT OF OCULAR DISORDERS
(FR) PREPARATION POUR LA PREVENTION ET LE TRAITEMENT DE TROUBLES OCULAIRES
Abstract: front page image
(EN)The present invention relates to a preparation for the prevention and/or treatment of ocular disorders which comprises: a. an aldose reductase inhibitor; b. an intra ocular pressure lowering component; and c. a component that increases ocular blood flow. Component a can be Chrysantemum morifolium, Bixa orellana, Ipomoea batatas Vaccinium myrtillus, Buddleia officinalis, Cistancha salsa or Glycyrhizza glabra extract. Component b can be a green tea extract, myrecetin, querecetin or tannin. Component c can be an isoflavon or a water soluble carotenoid.
(FR)La présente invention concerne une préparation pour la prévention et/ou le traitement de troubles oculaires qui comprend a. un inhibiteur d'aldoxy réductase; b. un composant abaissant la pression intra-oculaire; et c. un composant qui augmente le flux sanguin oculaire. Le composant a peut être un extrait de Chrysantemum morifolium, Bixa orellana, Ipomoea batatas Vaccinium myrtillus, Buddleia officinalis, Cistancha salsa ou de Glycyrhizza glabra. Le composant b peut être un extrait de thé vert, de la myrécétine, de la quercétine ou du tanin. Le composant c peut être une isoflavone ou un carotènoïde soluble dans l'eau.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)